bioMerieux recalls VIDAS chlamydia assay batches
This article was originally published in Clinica
Executive Summary
bioMerieux has recalled in the UK two batches of its VIDAS chlamydia CHL assay, following the discovery of stability problems with a raw material, which is "causing an accelerated degradation of performance". As a result of investigations carried out thus far, the company is urging users to re-test only those patients who were tested since July 24 2003 and for whom the result was negative with a value of 20 or greater.